SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dixie7777 who wrote (1511)	6/20/1998 4:01:00 PM
From: Andrew H	Read Replies (1) of 5402

Rich, you make things a lot more complicate than they really are. As I said, I am not working for anyone. Ask chirodoc what he thinks--he has known me for a while. Initially I objected to some of the hype and what I perceived to be misinformation on the board. That has toned down considerably. Meanwhile, I have been doing some reasearch on the company thanks to the many posts on the research thread by chirodoc. I can see they have an interesting product aimed at an extremely lucrative market. If they were a Nasdaq stock rather than a BB, SGNC would most assuredly command a higher price. I just try to call them as I see them and that often changes as I research and think about things. Of course they are in the very early stages of product development and the risk is very considerable since it remains unlikely their product will ever reach the market. Now that those concerns have been well publicized and discussed, let me say there is no reason why shareholders might not make a nice profit if they bought the stock at these levels. With the Battelle deal the downside for the near future at least, seems fairly limited.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next